Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Spine (Phila Pa 1976). 2012 Nov 1;37(23):1933–1946. doi: 10.1097/BRS.0b013e31825e21b2

Table 4. Treatment Effect of Surgery By Secondary Outcome Measures of Spinal Stenosis and Degenerative Spondylolisthesis Patients According to Body Mass Index*.

Outcome Obesity (2 groups) 1 Year 2 Years 3 Years 4 Years

SPS (RCT & OBS) Treatment Effect (95% CI) Treatment Effect (95% CI) Treatment Effect (95% CI) Treatment Effect (95% CI)

Stenosis Bothersomeness Index (0-24) (SE)§§ Normal or overweight (BMI < 30) -4.4 (-5.6,-3.2) -3 (-4.3,-1.8) -3.5 (-4.9,-2.2) -3.5 (-5,-2)
Obese (BMI ≥ 30) -5.3 (-6.8,-3.7) -5.3 (-6.9,-3.7) -3.3 (-5,-1.6) -4 (-5.8,-2.2)

pvalue 0.36 0.021 0.83 0.67

Low Back Pain Bothersomeness (0-6) (SE)¶¶ Normal or overweight -1.3 (-1.7,-0.9) -1.3 (-1.7,-0.9) -1.3 (-1.7,-0.9) -1 (-1.5,-0.5)
Obese -1.8 (-2.3,-1.3) -1.6 (-2.1,-1.1) -1.3 (-1.9,-0.7) -1.4 (-2,-0.8)

pvalue 0.15 0.33 0.98 0.26

Very/somewhat satisfied with symptoms (%) Normal or overweight 34.5 (24.3,44.8) 36.7 (26.1,47.4) 29.8 (18.2,41.5) 33.6 (21,46.1)
Obese 50.7 (39.5,61.9) 51 (39.3,62.7) 33 (19,47) 31.2 (16.4,46)

pvalue 0.044 0.08 0.73 0.85

Self-rated progress: major improvement (%) Normal or overweight 37.9 (28,47.7) 29.3 (18.6,40) 28.6 (17.2,39.9) 26.7 (14.3,39)
Obese 53.3 (42.5,64) 49 (37.5,60.5) 42 (29.7,54.4) 36.2 (23.9,48.5)

pvalue 0.042 0.02 0.11 0.15

Mental Component Summary (MCS)(0-100) (SE) †† Normal or overweight 1.5 (-0.4,3.4) 1.4 (-0.6,3.3) 0.9 (-1.2,3) 1.9 (-0.5,4.2)
Obese 0.6 (-1.8,2.9) 3.9 (1.5,6.4) 3.4 (0.8,6) 3.1 (0.3,5.9)

pvalue 0.53 0.099 0.13 0.49

DS (RCT & OBS)

Stenosis Bothersomeness Index (0-24) (SE)§§ Normal or overweight (BMI < 30) -5.2 (-6.4,-4) -5.1 (-6.3,-3.8) -4.7 (-6,-3.3) -5.1 (-6.5,-3.6)
Obese (BMI ≥ 30) -6.6 (-8.1,-5) -5.6 (-7.2,-3.9) -5.5 (-7.3,-3.6) -6.6 (-8.5,-4.8)

pvalue 0.16 0.63 0.48 0.18

Low Back Pain Bothersomeness (0-6) (SE)¶¶ Normal or overweight -1.2 (-1.6,-0.8) -0.8 (-1.2,-0.4) -0.7 (-1.1,-0.3) -0.9 (-1.4,-0.4)
Obese -1.5 (-2,-1) -1.2 (-1.7,-0.7) -0.8 (-1.4,-0.2) -1.3 (-1.9,-0.7)

pvalue 0.35 0.28 0.69 0.31

Very/somewhat satisfied with symptoms (%) Normal or overweight 42.7 (33.3,52.2) 39.4 (29.3,49.5) 26.5 (15.1,37.9) 30.3 (18.3,42.4)
Obese 50.8 (39.5,62.1) 31.5 (17.3,45.7) 36.1 (21.2,50.9) 43 (28.5,57.5)

pvalue 0.26 0.38 0.34 0.24

Self-rated progress: major improvement (%) Normal or overweight 44.4 (35,53.8) 47.9 (38.3,57.6) 48.4 (38.3,58.4) 43.7 (32.6,54.7)
Obese 59.4 (48.4,70.3) 52.4 (40.2,64.6) 40.3 (25.6,54.9) 49.7 (35.6,63.8)

pvalue 0.071 0.58 0.46 0.56

Mental Component Summary (MCS)(0-100) (SE) †† Normal or overweight 0.3 (-1.5,2.2) 1.2 (-0.7,3.2) 1.8 (-0.2,3.9) 2.7 (0.5,5)
Obese 3.5 (1.1,5.9) 2.5 (0,5.1) 3.7 (0.9,6.5) 1.6 (-1.4,4.6)

pvalue 0.038 0.41 0.29 0.56
*

Adjusted for age, gender, race, smoking status, compensation, joint, stomach, bowel, osteoporosis, number of moderate/severe stenotic levels, self-assessed health trend at baseline, treatment preference, baseline stenosis bothersomeness, other ** comorbiditiy, baseline score and center.

Treatment effect is the difference between the surgical and non-operative mean change from baseline. Analysis is done using a mixed model with a random subject intercept term. Treatment is a time-varying covariate where a patients' experience prior to surgery is attributed to the non-operative arm and time is measured from enrollment and his/her post-surgery outcomes are attributed to the surgical arm and time is measured from time of surgery.

§§

The Sciatica Bothersomeness index ranges from 0 to 24, with lower scores indicating less severe symptoms.

¶¶

The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms

††

The SF-36 scores range from 0 to 100, with higher score indicating less severe symptoms.

**

Other comorbidities include: stroke, cancer, fibromyalgia, chronic fatigue syndrome, post traumatic stress disorder, alcohol, drug dependency, lung, liver, kidney, blood vessel, nervous system, migraine, anxiety.